MDMarc-Werner Dobenecker

Marc-Werner Dobenecker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marc-Werner Dobenecker has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The catalytic domain of the histone methyltransferase NSD2/MMSET is required for the generation of B1 cells in mice

    by Marc‐Werner Dobenecker, Jonas Marcello, Annette Becker, Eugene Rudensky, Natarajan V. Bhanu, Thomas Carrol, Benjamin A. Garcia, Rabinder Prinjha, Vyacheslav Yurchenko, Alexander Tarakhovsky

    Humoral immunity in mammals relies on the function of two developmentally and functionally distinct B‐cell subsets—B1 and B2 cells. While B2 cells are responsible for the adaptive response to environmental antigens, B1 cells regulate the production of polyreactive and low‐affinity antibodies for innate humoral immunity. The molecular mechanism of B‐cell specification into different subsets is understudied. In this study, we identified lysine methyltransferase NSD2 (MMSET/WHSC1) as a critical regulator of B1 cell development. In contrast to its minor impact on B2 cells, deletion of the catalytic domain of NSD2 in primary B cells impairs the generation of B1 lineage. Thus, NSD2, a histone H3 K36 dimethylase, is the first‐in‐class epigenetic regulator of a B‐cell lineage in mice.


  • Open Access

    Histone methyltransferase MMSET/NSD2 is essential for generation of B1 cell compartment in mice

    by Marc-Werner Dobenecker, Vyacheslav Yurchenko, Jonas Marcello, Annette Becker, Eugene Rudensky, Natarajan V. Bahnu, Thomas Carrol, Benjamin A. Garcia, Brad R. Rosenberg, Rabinder Prinjha, et al.

    Humoral immunity in mice and man relies on the function of two developmentally and functionally distinct B cell subsets - B1 and B2 cells. While B2 cells are responsible for most of the adaptive response to environmental antigens, B1 cells, which are comprised of phenotypically distinct B1a and B1b cells, are carriers of the innate humoral immunity that relies on production of poly-reactive and low affinity antibodies. The molecular mechanism of B cell specification into different subsets is not well established. Here we identified lysine methyltransferase MMSET/NSD2 as a critical regulator of the B1 cell population. We show that NSD2 deficiency in B cell precursors prevents generation of the B1 cell compartment, while having a minor impact on B2 cells. Our data revealed MMSET/NSD2, which catalyzes histone H3 lysine 36 di-methylation, as the first in class epigenetic master regulator of a major B cell lineage in mice.


  • Open Access

    Signaling function of PRC2 is essential for TCR-driven T cell responses

    by Marc-Werner Dobenecker, Joon Seok Park, Jonas Marcello, Michael T. McCabe, Richard Gregory, Steven D. Knight, Inmaculada Rioja, Anna K. Bassil, Rabinder K. Prinjha, Alexander Tarakhovsky

    Differentiation and activation of T cells require the activity of numerous histone lysine methyltransferases (HMT) that control the transcriptional T cell output. One of the most potent regulators of T cell differentiation is the HMT Ezh2. Ezh2 is a key enzymatic component of polycomb repressive complex 2 (PRC2), which silences gene expression by histone H3 di/tri-methylation at lysine 27. Surprisingly, in many cell types, including T cells, Ezh2 is localized in both the nucleus and the cytosol. Here we show the presence of a nuclear-like PRC2 complex in T cell cytosol and demonstrate a role of cytosolic PRC2 in T cell antigen receptor (TCR)–mediated signaling. We show that short-term suppression of PRC2 precludes TCR-driven T cell activation in vitro. We also demonstrate that pharmacological inhibition of PRC2 in vivo greatly attenuates the severe T cell–driven autoimmunity caused by regulatory T cell depletion. Our data reveal cytoplasmic PRC2 is one of the most potent regulators of T cell activation and point toward the therapeutic potential of PRC2 inhibitors for the treatment of T cell–driven autoimmune diseases.


  • Open Access

    Coupling of T cell receptor specificity to natural killer T cell development by bivalent histone H3 methylation

    by Marc-Werner Dobenecker, Jong Kyong Kim, Jonas Marcello, Terry C. Fang, Rab Prinjha, Remy Bosselut, Alexander Tarakhovsky

    The fidelity of T cell immunity depends greatly on coupling T cell receptor signaling with specific T cell effector functions. Here, we describe a chromatin-based mechanism that enables integration of TCR specificity into definite T cell lineage commitment. Using natural killer T cells (iNKT cell) as a model of a T cell subset that differentiates in response to specific TCR signaling, we identified a key role of histone H3 lysine 27 trimethylation (H3K27me3) in coupling iNKT cell TCR specificity with the generation of iNKT cells. We found that the Zbtb16/PLZF gene promoter that drives iNKT cell differentiation possesses a bivalent chromatin state characterized by the simultaneous presence of negative and positive H3K27me3 and H3K4me3 modifications. Depletion of H3K27me3 at the Zbtb16/PLZF promoter leads to uncoupling of iNKT cell development from TCR specificity and is associated with accumulation of iNKT-like CD4+ cells that express a non-iNKT cell specific T cell repertoire. In turn, stabilization of H3K27me3 leads to a drastic reduction of the iNKT cell population. Our data suggest that H3K27me3 levels at the bivalent Zbtb16/PLZF gene define a threshold enabling precise coupling of TCR specificity to lineage commitment.